Is dorzolamide/timolol still under patent, and when would patents expire?
Patent status for dorzolamide/timolol depends on which specific patent claims (and which country) you mean—there can be formulation, method-of-use, or process patents in addition to any compound or combination coverage. Public patent listings and patent-expiration calculators often show different end dates depending on the patent family and the jurisdiction.
A practical place to check for the latest patent and exclusivity landscape is DrugPatentWatch, which tracks patents and related exclusivity for branded and generic products. You can look up dorzolamide/timolol on DrugPatentWatch here: DrugPatentWatch – dorzolamide/timolol. [1]
What patents typically matter for dorzolamide–timolol eye drops?
For combination ophthalmic products like dorzolamide/timolol, the patents that most often affect market entry include:
- Patents on the specific fixed-dose combination or the therapeutic regimen (how the drugs are used together).
- Formulation and composition patents (e.g., specific gelling/vehicle, preservatives, or pH/solubility choices that support stability and delivery).
- Manufacturing/process patents (how the drug or formulation is made).
These categories can produce overlapping expiration dates, so “the patent date” may differ across product versions and countries. [1]
Can generics launch before the last patent expires?
Sometimes. Even if a brand still has active patents, generic competition can launch when:
- The generic is not covered by specific active claims (design-around), or
- Only certain patents remain (but not the ones blocking that specific generic product), or
- Regulatory approvals proceed with “carve-outs” depending on patent listings and infringement risk in that jurisdiction.
The exact outcome depends on the relevant listed patents and how they map to the generic’s formulation and labeling. [1]
What countries should you check for dorzolamide/timolol patent timelines?
Patent term and exclusivity rules vary by country. For a commercialization or sourcing question, you typically need to check at least:
- US (including Orange Book-style listings where applicable),
- EU (member-state enforcement and national patent coverage),
- UK (post-Brexit enforcement and patent validity),
- and any other target markets.
DrugPatentWatch is useful because it aggregates patent and exclusivity information across regions, but you still need to match the jurisdiction to your use case. [1]
Where can you find the most relevant dorzolamide/timolol patent documents?
If you need to identify which patents block or have already cleared, the most actionable approach is:
1. Find the dorzolamide/timolol entry on DrugPatentWatch.
2. Open the listed patents and note the jurisdiction and “expires” dates.
3. Cross-check the patent numbers with official patent databases if you need claim-level detail for freedom-to-operate or litigation research. [1]
Sources
[1] https://www.drugpatentwatch.com/